Positions
- Assistant professor
-
Mol and Cell Biology
Baylor College of Medicine
Houston, Texas
Education
- Postdoctoral Training at Baylor college of medicine
- Houston, Texas United States
- Postdoctoral Fellowship at Ariel University
- Ariel, Israel
- PhD from Bar Ilan University
- 10/2015 - Ramat-Gan, Israel
- Medicinal Chemistry
Professional Interests
- Research interest
Professional Statement
My research is focused on drug combinations pursuing improved outcomes in cancer treatment. My primary interest is in the impact of small molecule drug combinations on tumor immunology.Websites
full list of publications on google scholar
Selected Publications
- Gilad Y., Firer M.A. and Gellerman G. "1- Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells." MDPI Biomedicines. 2016;
- Gilad Y., Noy E., Senderowitz H., Albeck A., Firer M.A. and Gellerman G. "2- Dual-drug RGD conjugates provide enhanced cytotoxicity of melanoma and non-small lung cancer cells." Biopolymers: Peptide Science. 2016;
- Gilad Y., Waintraub S., Albeck A. and Gellerman G. "3- Synthesis of novel protected Nα(ω-Drug) amino acid building units for use in linear synthesis of peptide-drug conjugates." Int J Pept Res Ther. 2016;
- Gilad Y., Noy E., Senderowitz H., Albeck A., Firer M.A. and Gellerman G. "4- Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery." Bioorg. Med. Chem.. 2016;
- Gilad Y., Firer M.A., Rozovsky A., Ragozin E., Redko B., Albeck A. and Gellerman G. "5- "Switch off/switch on" regulation of drug cytotoxicity by conjugation to a cell targeting peptide." EJMC. 2014;
- Gellerman G., Baskin S., Galia L., Gilad Y. and Firer M.A. "6- Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide." Anticancer Drugs. 2013;
- Brider T., Gilad Y., Gellerman G. "7- A fast entry to the novel medicinally-important 9-anilinoacridine peptidyls by solid phase organic synthesis (SPOS)." Tetrahedron Lett. 2011;
- Y. Gilad, H. Tuchinsky, G. Ben-David, R. Minnes, Gancz, H. Senderowitz, G. Luboshits, M.A. Firer, G. Gellerman "Discovery of potent molecular chimera (CM358) to treat human metastatic melanoma." EJMC. 2017 Jul;
Log In to edit your profile